Connect with us

Uncategorized

Australis and 3 Rivers Biotech Enter into Tissue Culture Joint Venture

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) today announced that the Company has entered into a binding terms sheet concerning a joint venture (JV) partnership with 3 Rivers Biotech Inc. (“3 Rivers”), a leading agricultural technology company specialised in commercial scale micropropagation, or plant tissue culture (PTC), for cannabis, hemp and traditional crops. The JV […]

The post Australis and 3 Rivers Biotech Enter into Tissue Culture Joint Venture appeared first on Technical420.

Republished by Plato

Published

on

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) today announced that the Company has entered into a binding terms sheet concerning a joint venture (JV) partnership with 3 Rivers Biotech Inc. (“3 Rivers”), a leading agricultural technology company specialised in commercial scale micropropagation, or plant tissue culture (PTC), for cannabis, hemp and traditional crops.

Australis Capital Inc. Logo (CNW Group/Australis Capital Inc.)

The JV

Under the terms of the agreement, AUSA and 3 Rivers will own 15% and 85% of the JV, respectively. The intent of the JV is to jointly market the 3 Rivers’ offerings to growers. Through the JV, 3 Rivers will provide access to its IP and innovative services, products and solutions to AUSA sourced clients. These innovations include all current 3 Rivers offerings as well as access to future products such as PTC-based auto-flowering genetics, which provides a clonal hemp or cannabis plant that will flower independent of day length. This is a potential game changer for outdoor growers. AUSA will contribute sales and marketing capabilities and, through its deep industry network, the ability to generate new opportunities.

The Opportunity

With over 1,000 cannabis companies, close to 600,000 acres planted with hemp in North America and Europe alone (representing approximately 1.1 billion plants) 1 , as well as 1.3 million acres 2 (~56.6 billion square feet) of global greenhouse vegetable area, the opportunity for 3 Rivers is very substantial (these numbers leave out greenhouse production of fruit). Through its innovative offerings and in particular its nearly peerless capabilities in cannabis and hemp, the company is exceptionally well positioned to deliver significant growth. The joint venture with AUSA will generate mutual benefits through increased access to marketing channels addressing the various markets both AUSA and 3 Rivers operate in.

Advantages of PTC

PTC entails growing a plant from a small number of cells, rather than from seeds or clones, under strictly controlled sterile conditions in a nutrient medium. PTC has numerous benefits with a significant positive impact on growers’ economic returns:

  • Increased facility ROI through true Generation Zero plantlets: PTC delivers disease-free starting material, increasing vigor (faster and healthier growth), and improved metabolite (cannabinoid or terpene) expression (greater product quality), increasing the economic return of a facility
  • Increased facility efficiencies: when adopting PTC, a cultivator no longer requires a mother room, thereby freeing up licensed space for flowering of commercially valuable crop, increasing a facility’s yield
  • Risk Mitigation
    • Reduced risk of crop failure due to pathogen infestation
    • 100% feminized stock avoids risk of rogue male plants, which can destroy an entire harvest
    • 100% traceability of inputs, genetics, and biomass reduces compliance risks
    • Reduced chance of failing strict pesticide testing with clean, laboratory-produced plants
  • Ability to remove pathogens from existing cultivars: producing ‘clean’ plantlets, enhancing yield and quality of a new crop
  • Preservation of Rare or Endangered Species
  • Accelerated Propagation Once a Plant is in Tissue Culture
  • Improved Logistics
  • Shortened Breeding Cycle: accelerated amelioration & genetic variability
  • Improved Harvest Timing: reducing labor requirement s

The 3 Rivers Offering

3 Rivers Biotech is a plant biotechnology company specializing in commercial scale plant tissue culture for cannabis, hemp and traditional crops to provide premium pathogen-free, pesticide-free, vigorous plants to cultivators and late-stage nurseries across the United States and Internationally. The 3 Rivers products and services include:

  • Supply of micropropagation derived genetics, disease free Generation Zero plantlets for cannabis, hemp and other traditional crops (fruits, flowers, ornamentals, vegetables, etc.)
  • Ongoing PTC facility management and medium supply services
  • Clean-up of existing genetics: delivering a new generation of disease-free plantlets to growers
  • Storage of rare and valuable cultivars: genetics are the core property based on which growers generate revenues and establish brands. Genetics are therefore exceptionally valuable and safeguarding these is of great importance. PTC enables the indefinite preservation of these genetics.
  • Genetic fingerprinting: ensuring traceability and IP protection
  • Pathogen testing: screening for all predatory viruses, fungi, and oomycetes
  • Technology Transfer:
    • 3 Rivers has developed a production ready, prefabricated PTC lab, capable of producing up to 500,000 plantlets per year, the so-called InstaLab. These InstaLabs, which can be shipped anywhere in the world, greatly accelerate a company’s ability to implement PTC at commercial scale
    • 3 Rivers also designs and develops PTC production as part of a retrofit of existing facilities, or integrated into the design of new facilities

Further innovations around Integrated Pest Management and the delivery of PTC-stable autoflowering varieties, on which the company has a provisional patent, are under development.

Management Commentary

Dr. Duke Fu , Interim CEO of AUSA, stated, “We believe this new partnership will set the standard for science-based micropropagation, and be accretive to AUSA’s results. Being able to offer the propagation of cannabis through tissue culture at commercially viable scale is something that many companies and scientists have attempted, but that very few, if any, have managed to accomplish. This makes the 3 Rivers capabilities unique. The JV provides AUSA with access to an expanded portfolio of extremely valuable IP. We also believe this will strengthen our ability to execute on our capital-light strategy. For instance, being able to offer cultivation partners with PTC reduces the need for our cultivars to take up space in their facilities’ mother rooms, increasing the yield of any given facility. This JV further cements AUSA’s position as an authentic differentiator by offering a unique value add service that is exceptionally difficult to replicate.”

Robert Allen , CEO of 3 Rivers, added: “This partnership is transformative to 3 Rivers. By teaming up with AUSA, we believe we will be able to access new sales and marketing channels and rapidly expand our global footprint for PTC of cannabis, hemp and traditional crops. The JV accelerates our ability to bring our commercially focused innovations to market by gaining access to a deep industry network of industry leaders and operators, and help establish 3 Rivers as the leading company in this exciting and economically rewarding field.”

About 3 Rivers

3 Rivers is operational in Canada and Washington State , and is expanding into California and other jurisdictions. Its Washington cannabis operations, serving the local market, are at capacity and the company is in the process of expanding its in-state capacity. Its California operations anticipate internal, partner driven demand to grow to approximately 4-5 million plantlets in the coming years, with further growth coming through external sales.

Through its partnership with JRT Nurseries and its large-scale Mount Vernon tissue culture facility, 3 Rivers has the ability to scale and ship plants globally. This facility is one of the largest and most reputable plant tissue culture nurseries in North America , capable of producing over 12+ million plants annually. TheMount Vernon facility will be leveraged to service global markets for micro-propagated traditional crops, such as soft fruits and vegetables.

3 Rivers eliminates the risks and variables of commercial cultivation by providing its customers with stable genetics and vigorous, disease-free clones. The deeply experienced 3 Rivers team, with over 50 million plants supplied and counting, has been focused on perfecting plant propagation for decades. The unique combination of commercial scale PTC for cannabis, science-based R&D on applications with a rapid time to market and broad service offering have resulted in 3 Rivers rapidly expanding into becoming a world leader in its field.

About AUSA

AUSA is implementing a growth strategy towards establishing a highly competitive and profitable MSO in the U.S. and global cannabis markets. AUSA’s business and assets include investments in Cocoon, Body and Mind Inc., Quality Green, Folium Biosciences, and land assets in Washington and Michigan . AUSA is currently working towards the closing of a transaction whereby it will acquire 51% of ALPS, the world’s premier design, construction management, commissioning and post commissioning consultancy for horticultural crops, such as cannabis, fruits, vegetables, mushrooms and algae. If completed, the Company will also hold an option for the acquisition of the remaining 49% of ALPS. AUSA is also working towards completing the acquisition of Green Therapeutics LLC, an award-winning MSO with operations in Nevada , Missouri and Oklahoma . Through GT and ALPS, the Company believes it will be able to secure low-cost access to cannabis biomass to fuel the scale up of its award-winning brands across the U.S. and global cannabis markets.

The Company’s common shares trade on the CSE under the symbol “AUSA” and on the OTCQB under the symbol “AUSAF”.

For further information about AUSA, please contact:

Marc Lakmaaker
Marc.lakmaaker@ausa-corp.com
T: +1.647.289.6640

For further information on 3 Rivers, please contact:

Kevin Mehr
3 Rivers Biotech Ltd.
info@3riversbiotech.com

Forward-Looking Statement

This press release contains “forward-looking information” within the meaning of applicable securities legislation. All statements, other than statements of historical fact, included herein is forward-looking information. Generally, forward-looking information may be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “proposed”, “is expected”, “budgets”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. In particular, this press release contains forward-looking information in relation to: the the joint venture between AUSA and 3 Rivers closing and the ability to operate and execute; the timing and ability to close the proposed transactions with GT and ALPS; the anticipated development of the GT and ALPS businesses; the ability of the Company to execute on its strategy to establish a low capex model MSO; the impact of the changes to U.S. federal and state developments with respect to the cannabis industry and the opportunities this may present for the Company. This forward-looking information reflects the Company’s current beliefs and is based on information currently available to the Company and on assumptions the Company believes are reasonable. These assumptions include, but are not limited to: the ability of the Company to successfully satisfy the conditions to closing the ALPS and GT transactions; the ability of management of ALPS, GT and the Company to successfully execute on their respective business plans; legal changes relating to the cannabis industry proceeding as anticipated; and the Company’s continued response and ability to navigate the COVID-19 pandemic being consistent with, or better than, its ability and response to date.

Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; the actual results of the Company’s future operations; competition; changes in legislation affecting the Company; the timing and availability of external financing on acceptable terms; lack of qualified, skilled labour or loss of key individuals; risks related to the COVID-19 pandemic.

A description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in the Company’s disclosure documents on the SEDAR website at www.sedar.com . Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking information. Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking information contained in this press release is expressly qualified by this cautionary statement. The forward-looking information contained in this press release represents the expectations of the Company as of the date of this press release and, accordingly, are subject to change after such date. However, the Company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accept responsibility for the adequacy or accuracy of this release.

Cision

View original content to download multimedia: http://www.prnewswire.com/news-releases/australis-and-3-rivers-biotech-enter-into-tissue-culture-joint-venture-301239492.html

SOURCE Australis Capital Inc.

 

Cision

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2021/03/c5342.html Checkout PrimeXBT
Trade with the Official CFD Partners of AC Milan
Source: https://technical420.com/cannabis-article/australis-and-3-rivers-biotech-enter-into-tissue-culture-joint-venture/

Uncategorized

Massachusetts Marijuana Retailer License Application

The post Massachusetts Marijuana Retailer License Application appeared first on Cannabis Industry Lawyer – Tom Howard.

Republished by Plato

Published

on

Massachusetts Marijuana Retailer License

Massachusetts Marijuana Retailer License Application

Applying for a Massachusetts Marijuana Retailer License is the first step any cannabis entrepreneur that resides in the bay state should take care of if they want to open a dispensary.

The Cannabis Control Commission (CCC) is responsible for promulgating regulations relating to marijuana, processing business applications and issuing licenses, and creating policies and procedures which “promote and encourage full participation in the regulated marijuana industry by people from communities that have previously been disproportionately harmed by marijuana prohibition and enforcement and to positively impact those communities.

According to the latest legislation, a Massachusetts Marijuana Retailer License is a legal document which authorizes entities to purchase and deliver marijuana and marijuana products from Marijuana Establishments and to sell or otherwise transfer marijuana and marijuana products to Marijuana Establishments and to consumers.

According to the CCC, similar to marijuana for medical use, edible marijuana products for adult use shall not be considered food and therefore Marijuana Retailers would not be subject to inspection by local Boards of Health under 105 CMR 590 unless local regulations requiring such inspections are promulgated.

A Marijuana Retailer provides a retail location which may be accessed by consumers 21 years of age or older or, if the retailer is co-located with a RMD by individuals who are registered qualifying patients with the Medical Use of Marijuana Program with a registration card.

How to apply for a Massachusetts Marijuana Retailer License

The first step to applying for a Massachusetts Marijuana Retailer License is to submit the license application fee and all three (3) sections of the application:

  • Application of Intent,
  • Background Check, and
  • Management and Operations Profile.

Each section requires applicants to provide accurate information about the business, individuals and entities associated with the business and to demonstrate understanding of, and plans to comply with, the Commission’s regulations that are specific to the applicant’s license type, location, and scale. The adult- and medical-use license applications have essentially the same requirements with differences highlighted in the following sections.

In order to submit these sections, you’d need to create an account in MassCIPortal’s webpage and log into the portal, navigate through the page and start the application virtually.

Application of Intent

The Application of Intent (AOI) requires the applicant to disclose Persons or Entities Having Direct or Indirect Control in their application for licensure. Persons or Entities Having Indirect Control means any person or entity having indirect control over operations of a ME or MTC. It specifically includes any person with a controlling interest in an indirect holding or parent company of the applicant, and the chief executive officer and executive director of those companies, or any person or entity in a position indirectly to control the decision-making of a Marijuana Establishment (ME) or a Marijuana Treatment Center (MTC).

Applicants are encouraged to include individuals that exert control through the contribution of services. For example, an individual may exert control by making decisions about the establishment management or operations. Applicants do not need to disclose individuals who provide services and do not exert control. For example, applicants do not need to disclose consultants who consult but do not make decisions for the establishment.

In this phase, all applicants would have to disclose and submit the following:

  • In-State Interests
  • Out-of-State Interests
  • Capital Resources
  • Bond or Escrow
  • Property Identification and Interest Documentation
  • Host Community Agreement Certification
  • Community Outreach Meeting Attestation and Documentation
  • Plan to Remain Compliant with Local Ordinance
  • Plan to Positively Impact Disproportionately Harmed People
  • Application Fee

RELATED POST: MAINE MARIJUANA LICENSE: HOW TO APPLY

RELATED POST: CANNABIS SPAC

Background Check

In this phase of the Massachusetts Cannabis License Application, all applicants must list all relevant individuals and entities along with all background disclosures and authorization forms. Each individual or entity listed in the Applicant of Intent section shall also be listed in the Background Check section. Individuals and entities will undergo an in-depth background check and individuals will submit to fingerprinting checks. 

The Commission is required to make a determination of suitability for licensure for each individual and entity listed on an application, which is based, in part on the background checks. Background checks will include, but not be limited to, a review of the following:

  • Massachusetts’ and national criminal database records; 
  • Massachusetts’ and national civil database records, including professional and occupational records; 
  • The individual and entity’s involvement in other marijuana-related businesses; and
  • Any actions taken against any license or registration held by the individual or entity. 
  • Further, all applicants will be required to disclose the following information:
  • A description of any criminal action, whether felony or misdemeanor, that resulted in a conviction, guilty plea, plea of nolo contendere, or admission to sufficient facts; 
  • A description of any civil action, including actions related to a professional, occupational, or fraudulent practice; 
  • A description of any administrative action, including actions related to a medical- or adult-use marijuana operation; 
  • A description of any disciplinary action taken in any jurisdiction against a license, registration, or certification held by the individual or entity, such as a suspension or revocation, including, but not limited to, a license to prescribe or distribute controlled substances; and 
  • A description of any license denial.

Applicants are not required to provide information about any conviction that has been sealed or expunged by court order.

Management and Operations Profile 

The information required as part of this section is an indicator that the applicant understands the legal requirements to operate an ME, including the Commission’s regulations, has plans that are specific to the applicant’s license type, location and scale. and will be able to operate in a lawful manner.

In order to comply with this phase of the Massachusetts Cannabis License application, all applicants would need to provide the following:

  • Business Information, Articles of Organization, and Bylaws
  • Certificates of Good Standing
  • Business Plan, Liability Insurance Plan, & Proposed Timeline
  • Summary of Operating Plans, Policies, and Procedures
  • Diversity Plan

Taxes on retail sales

An excise tax is hereby imposed upon the sale of marijuana or marijuana products by a marijuana retailer to anyone other than a marijuana establishment at a rate of 3.75 per cent of the total sales price received by the marijuana retailer as a consideration for the sale of marijuana or marijuana products. The excise tax shall be levied in addition to state tax imposed upon the sale of property or services as provided in section 2 of chapter 64H of the General Laws and shall be paid by a marijuana retailer to the commissioner at the time provided for filing the return required by section 16 of chapter 62C of the General Laws

Any city or town may impose a local sales tax upon the sale or transfer of marijuana or marijuana products by a marijuana retailer operating within the city or town to anyone other than a marijuana establishment at a rate not greater than 2 per cent of the total sales price received by the marijuana retailer as a consideration for the sale of marijuana or marijuana products. A marijuana retailer shall pay a local sales tax imposed under this section to the commissioner at the same time and in the same manner as the sales tax due to the commonwealth.

All sums received by the commissioner under this section shall not be considered received on account of the commonwealth and shall at least quarterly be distributed, credited and paid by the state treasurer upon certification of the commissioner to each city or town that has adopted this section in proportion to the amount of such sums received from the sale or transfer of marijuana and marijuana products in the city or town.

What are the costs for a Massachusetts Cannabis License?

In order to obtain a Massachusetts Cannabis Retail License, there’s no minimum amount of capital resources that must be demonstrated. In this sense. In this sense we’d recommend any ME applicant to aim for $250,000 – $1,000,000 depending on the size and scope of their operation.

Further, applicants are required to set aside, either through a bond or an escrow account, an amount of money sufficient to cover the dismantling and winding down of the Marijuana Establishment. The amount set aside must be enough to cover the cost of satisfying any outstanding state or municipal sales tax obligations, costs incurred securing the licensee’s facility, and cost incurred for destroying the marijuana and marijuana products in its inventory. 

If the applicant acquires a bond, the applicant is required to set aside the total amount of their licensing fees as set forth in 935 CMR 500.005 or 501.005, even if the fees have been waived. If the applicant establishes an escrow account, the applicant must set aside at least $5,000 and is encouraged to set aside the total amount of their licensing fees, even if the fees have been waived. 

If the applicant acquires a bond, the bond should reflect the following:

  • The applicant is the Principal;
  • The Commonwealth of Massachusetts Cannabis Control Commission, 2 Washington Square, Worcester, MA, 01604, is the obligee; 
  • The purpose of the bond is to cover any costs incurred by the Commission to satisfy any outstanding state and local sales tax obligations, costs incurred to secure any licensed marijuana facility, costs incurred to destroy the marijuana and marijuana products in its inventory, and to cover other costs incurred by the Commission or its designee in dismantling or winding down of the licensee’s facility in accordance with its policies and governing laws. 

If the applicant establishes an escrow account, the account should reflect the following:

  • The Commonwealth of Massachusetts Cannabis Control Commission, 2 Washington Square, Worcester, MA, 01604, is the sole beneficiary; and 
  • The purpose of the bond is to cover any costs incurred by the Commission to satisfy any outstanding state and local sales tax obligations, costs incurred to secure any licensed marijuana facility, costs incurred to destroy the marijuana and marijuana products in its inventory, and to cover other costs incurred by the Commission or its designee in dismantling or winding down of the licensee’s facility in accordance with its policies and governing laws

RELATED POST: MAP OF MARIJUANA LEGALITY BY STATE

RELATED POST: NEW JERSEY DISTRIBUTOR LICENSE

Virginia Marijuana Establishment Licenses

Virginia Marijuana Establishment Licenses Recently -on April 7- HB 2312 and SB 1406 were voted to be approved after Gov. Ralph Northam requested amendments from the legislature.  This bill will replace cannabis prohibition with a system to legalize, tax, and regulate…

Connecticut Cannabis Establishment License

Connecticut Cannabis Establishment License: How to Apply In February of this year, Gov. Ned Lamont proposed a legislation that would permit the sale and possession of recreational marijuana in Connecticut, starting in 2022 and relying on the existing infrastructure of…

Thomas Howard

Thomas Howard

Cannabis Lawyer

Thomas Howard has been in business for years and can help yours navigate towards more profitable waters.

Maine Marijuana License: How to Apply

Maine Marijuana Licenses A Maine Marijuana License is a legal document that allows its holder to commercialize or otherwise work with cannabis in the state of Maine. Though adult-use marijuana was legalized in 2016, Maine did not establish regulations for commercial…

New Jersey Cannabis Delivery License

New Jersey Cannabis Delivery License A Class 6 Delivery License is a legal document that allows its owner to provide courier services for consumer purchases of cannabis items and related supplies fulfilled by a cannabis retailer in order to make deliveries of the…

New Jersey Cannabis Retailer License

New Jersey Cannabis Retailer License A Class 5 Retailer License is a legal document that allows its owner to purchase or otherwise obtain usable cannabis from cannabis cultivators and cannabis items from cannabis manufacturers or cannabis wholesalers, and sell these…

New Jersey Cannabis Distributor License

New Jersey Cannabis Distributor License A New Jersey Cannabis Distributor License is a legal document that allows its owner to transports cannabis in bulk intrastate from one licensed cannabis cultivator to another licensed cannabis cultivator, or transports cannabis…

New Jersey Cannabis Wholesaler License

New Jersey Cannabis Wholesaler License Entrepreneurs have now set their eyes on the Garden State, now that last month Gov. Phil Murphy signed the New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (NJ CREAMMA) into law.  The…

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://www.cannabisindustrylawyer.com/massachusetts-marijuana-retailer-license/

Continue Reading

Uncategorized

Pure Extracts Commences Initial Production Run of 50,000 Gummie Packs for Provincial Distribution

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that it has commenced production on approximately 50,000 Pure Chews edible gummie packs. Demand for these types of products is […]

The post Pure Extracts Commences Initial Production Run of 50,000 Gummie Packs for Provincial Distribution appeared first on Technical420.

Republished by Plato

Published

on

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that it has commenced production on approximately 50,000 Pure Chews edible gummie packs.

Demand for these types of products is strong in the 4 provinces (British Columbia, Alberta, Saskatchewan and Ontario) that the Company is targeting for its retail launch and revenue estimates associated with this batch are approximately $200,000. All the Pure Chews SKUs including the 10 mg THC packs of Fire Burst, Strawberry and Mango utilize a proprietary manufacturing system licensed from US based Taste-T, LLC (“Taste-T”), the manufacturer of Margarita Chill and Fireball Cinnamon products, to produce and package branded cannabis gummies that come in unique blister packaging.

Additionally, in the launch the Company plans to include 3 SKUs with varying levels of ultra-high potency CBD Pure Chews non-THC gummies.

Pure Extracts CEO, Ben Nikolaevsky, remarked, “May is going to be a very exciting month for us as we commence retail sales of gummies through our distribution partner. We plan to replicate the success that our licensing partner, Taste-T, is experiencing in US states including Nevada, Massachusetts, Michigan and Oklahoma. Our exceptionally pure products are in high demand and we have a range in potencies and flavours that consumers will certainly enjoy.”

About Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ)
Pure Extracts features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. On September 25, 2020, Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act and the Company’s stock began trading on the Canadian Securities Exchange (CSE) on November 5, 2020. Find out more at https://pureextractscorp.com/.

For further information please contact Empire Communications Group at (604) 343-2724 and ir@empiregroupir.com.

ON BEHALF OF THE BOARD
Ben Nikolaevsky
Ben Nikolaevsky
CEO and Director

The CSE has neither approved nor disapproved the contents of this press release.

This news release contains forward-looking statements relating to the future operations of Pure Extracts, and the other statements are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of Pure Extracts, are forward-looking statements and involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the expectations of Pure Extracts include risks detailed from time to time in the filings made by Pure Extracts under securities regulations.

Primary Logo

Share Share - Facebook Share - Twitter

Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners LLC. SBP continues to drive market awareness for leading firms in the cannabis industry throughout the U.S. and abroad.

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://technical420.com/cannabis-article/pure-extracts-commences-initial-production-run-of-50000-gummie-packs-for-provincial-distribution/

Continue Reading

Uncategorized

A Newbie’s Guide to Buying Online CBD Products for the First Time

hemp

Editors Note: This is a guest post.  It is the 21st Century- a  world where we can get almost anything the heart desires simply by ordering it online and having it delivered straight to the doorstep. And, the cannabis industry is no different today.  The slow but steady movement of marijuana’s use shows heavy documentation […]

The post A Newbie’s Guide to Buying Online CBD Products for the First Time appeared first on Green Market Report.

Republished by Plato

Published

on

Editors Note: This is a guest post. 

It is the 21st Century- a  world where we can get almost anything the heart desires simply by ordering it online and having it delivered straight to the doorstep. And, the cannabis industry is no different today. 

The slow but steady movement of marijuana’s use shows heavy documentation and has gained support from the consumers, especially the medical cannabis users. However, there remains a lot of mystery around the cannabis purchase process. Yes, people engage in regular workarounds for purchasing cannabis. 

But, no longer!

Yes, buying weed is pretty simple, provided you engage in a convenient and straightforward process, as described. Cannabis enthusiasts, can’t wait to know how? Well, let’s get going:

  • Embark on the research process:

When ordering marijuana products, it becomes vital to account for where you reside. After that, get informed and be sure that you aren’t falling under any scams or scrolling through any sketchy website. Ensure that the website you’re ordering CBD Products from looks legitimate and has reviews and publications from different customers. Dwell well on the reviewers and make sure they use different sets of words to express themselves differently. 

After all, you never wish to engage in illicit and fraudulent seller activities.

  • Know that you’re not scammed:

Let’s face it; a gazillion scammers are waiting to entrap you, especially when you buy weed. Thus, here are a few things that you must look for while purchasing weed:

  1. Open all eyes if the service asks you to pay through credit card or in advance.
  2. An online store that’s willing you to ship weed across state lines.
  3. An unlicensed dispensary.
  4. Anyone who offers you to mail weed. 
  5. The social media business is offering you to sell weed. 

Know that the online cannabis marketplace is a budding business model. Thus, with the flexibility of government regulations, the options have been changing and becoming standardized. 

  • Check online for reviews:

It is pretty unlikely for a reputable weed supplier not to have much knowledge of drugs and supplements. Please take note of the product reviews and ensure that they are complete and pretty exhaustive. Attain a clear picture of the correct dosage, symptoms, effects, and anything else that you as a buyer must know. 

The website and product description page will shed sufficient light on the seller’s credibility and trustworthiness. Thus, a single look will be enough to invite you as a customer. Care and efforts will be enough to spot. Also, the bottom line revolves around following your gut feeling. 

Another good sign that comes as a thumbs up for the product quality is the cost. Thus, closely check the price tag. These should never be too high or too low. 

If you’re ordering in bulk, ensure availing coupons and other vouchers. Thus, it seems like a great incentive for going in for an online dispensary. The best deal for buying top-notch products at pocket-friendly prices involves having attractive options for bulk purchasing. 

Key Takeaways

Ordering weed can be pretty simple as ordering pizzas or groceries. Just make sure you have your ID and cash. Apart from these, take a look at the customer support services that your choicest dispensary offers, in addition to the payment option, and then you’re good to go with weed!


Post Views:
133

Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://www.greenmarketreport.com/a-newbies-guide-to-buying-online-cbd-products-for-the-first-time/?utm_source=rss&utm_medium=rss&utm_campaign=a-newbies-guide-to-buying-online-cbd-products-for-the-first-time

Continue Reading
Uncategorized3 days ago

Halo Collective Announces New Appointment to Board of Directors and Completes Securities Issuance to Independent Consultants, Related Parties, and Suppliers

Metal3 days ago

Registration open for IHEA annual meeting

Heartland17 hours ago

Real Brands Inc. CEO Discusses Corporate Goals and Resolve in Audio Interview with …

Heartland5 days ago

CBD Shopping Guide 2021

Heartland5 days ago

Cannabis with a Conscience

Heartland5 days ago

Heartland5 days ago

Heartland5 days ago

Heartland5 days ago

Heartland5 days ago

Day two on CBD.

Heartland5 days ago

Heartland5 days ago

Heartland4 days ago

Heartland5 days ago

Hemp Seed Peptide Market Intelligence Study for Comprehensive Insights

Heartland4 days ago

Heartland4 days ago

Heartland5 days ago

RAB arrests drug dealers, recovers yaba, hemp

Heartland4 days ago

Heartland5 days ago

Heartland5 days ago

Day two on CBD.

Heartland4 days ago

Heartland3 days ago

Asia Pacific IoT command centre to be established in Adelaide

Heartland3 days ago

does cbd help with dizziness?

Heartland1 day ago

I just bought this brand that I have never seen before. Has anyone ever heard of it?

Heartland14 hours ago

Harvard Study Finds Cannabis Effective for Chronic Pain

Heartland7 hours ago

First time with WNC or any Indoor CBD in general.

Heartland2 days ago

Are Delta-8 THC Syringes the Most Practical Way to Medicate?

Heartland5 days ago

Heartland5 days ago

Not My Job: We Quiz Conan Sidekick Andy Richter On 'Conan The Destroyer' and CD Review …

Heartland5 days ago

CBD is amazing! Helped me finally stop smoking

Trending

A Cloud Nine Capital Entity Copyright © 2020 – All Rights Reserved Proudly Made in America